Variant report
Variant | esv3442938 |
---|---|
Chromosome Location | chr6:142323884-142326632 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs535997321 | chr6:142323927-142323928 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs554251644 | chr6:142323947-142323948 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs188604583 | chr6:142323969-142323970 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs111497683 | chr6:142323976-142323977 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs112945143 | chr6:142323982-142323983 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs576754363 | chr6:142323995-142323996 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs139757216 | chr6:142324005-142324006 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs116079607 | chr6:142324043-142324044 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs186080331 | chr6:142324052-142324053 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs149390273 | chr6:142324069-142324070 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs368951958 | chr6:142324075-142324076 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs114885978 | chr6:142324138-142324139 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs144544605 | chr6:142324154-142324155 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs546306992 | chr6:142324167-142324168 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs148445217 | chr6:142324174-142324175 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs144100080 | chr6:142324191-142324192 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs146509701 | chr6:142324195-142324196 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs139980759 | chr6:142324198-142324199 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs76314747 | chr6:142324221-142324222 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs190055868 | chr6:142324265-142324266 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs565695232 | chr6:142324287-142324288 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs372013335 | chr6:142324301-142324302 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs11758425 | chr6:142324304-142324305 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs570397146 | chr6:142324358-142324359 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs554858967 | chr6:142324373-142324374 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs116159503 | chr6:142324429-142324430 | Weak transcription Enhancers Active TSS Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs542602120 | chr6:142324497-142324498 | Weak transcription Enhancers Active TSS Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs143149189 | chr6:142324517-142324518 | Weak transcription Enhancers Active TSS Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs151150769 | chr6:142324607-142324608 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs17071344 | chr6:142324609-142324610 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs187240769 | chr6:142324635-142324636 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs575899150 | chr6:142324641-142324642 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs377230043 | chr6:142324675-142324676 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs116642603 | chr6:142324691-142324692 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs114185777 | chr6:142324732-142324733 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs200740267 | chr6:142324751-142324752 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs528487795 | chr6:142324787-142324788 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs540586168 | chr6:142324837-142324838 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs34415342 | chr6:142324842-142324843 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs559409057 | chr6:142324860-142324861 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs190870968 | chr6:142324862-142324863 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs182131958 | chr6:142324876-142324877 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs534531328 | chr6:142324891-142324892 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs185607652 | chr6:142324918-142324919 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs190071069 | chr6:142324937-142324938 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs183060938 | chr6:142324981-142324982 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs9389967 | chr6:142324989-142324990 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs9403364 | chr6:142324990-142324991 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs373618900 | chr6:142325003-142325004 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs375441019 | chr6:142325022-142325023 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Autism | 22495311 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Gastric cancer | 17908304 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
Developmental delay | 19490664 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
Breast cancer | 21364760 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Prostate cancer | 18632612 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Endocrine pancreatic tumor | 17914106 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:142310800-142334400 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
2 | chr6:142311000-142329000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
3 | chr6:142312200-142329000 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
4 | chr6:142320800-142330200 | Weak transcription | HSMM | muscle |
5 | chr6:142322200-142324200 | Weak transcription | K562 | blood |
6 | chr6:142324200-142324400 | Enhancers | K562 | blood |
7 | chr6:142324400-142324600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
8 | chr6:142324400-142324600 | Active TSS | Muscle Satellite Cultured Cells | -- |
9 | chr6:142324400-142324600 | Genic enhancers | K562 | blood |
10 | chr6:142324600-142326200 | Weak transcription | K562 | blood |
11 | chr6:142324600-142335000 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
12 | chr6:142326200-142326600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
13 | chr6:142326200-142326800 | Enhancers | K562 | blood |